Korean pharmaceutical giant gets top rating in ESG

Pictured above is the head office of Celltrion in South Korea. [Photo courtesy of Celltrion]
Pictured above is the head office of Celltrion in South Korea. [Photo courtesy of Celltrion]

South Korea's Celltrion announced on Nov. 21 that it has received an overall “A” rating in this year’s ESG evaluation conducted by the Korea Institute of Corporate Governance and Sustainability (KCGS).

The biopharmaceutical company noted that the exploit marked the second consecutive year the company has earned the designation. 

Celltrion added that the recognition reflected its continued progress in embedding environmental, social, and governance principles across its business operations.

KCGS, a nonprofit organization established to promote sustainable corporate growth and strengthen trust in the capital markets, conducts annual evaluations of companies based on their environmental management, social responsibility, and governance practices. 

The institute assigns ratings each year that have become an important benchmark for investors and stakeholders assessing corporate sustainability.

Celltrion’s consistent efforts to enhance its ESG framework and improve performance across all areas resulted in another year of high scores, reaffirming its position as a leading ESG-focused company, according to the firm.

The corporation has established clear targets in each of the environmental, social, and governance categories and follows a structured approach to tracking and improving its progress.

In the environmental field, Celltrion received favorable assessments for setting medium- and long-term goals related to key indicators such as energy use, water consumption, and waste management. 

The company has also expanded the use of eco-friendly packaging materials and advanced resource-circulation initiatives, demonstrating a sustained commitment to environmental responsibility.

"Achieving an integrated A rating for the second consecutive year highlights the successful and stable implementation of ESG principles across the company," a Celltrion representative said.

"Celltrion will continue fulfilling its social responsibilities as a global biopharmaceutical company while strengthening sustainable management practices to enhance corporate value and trust."

Short for Environmental, Social, and corporate Governance, ESG refers to the three major factors used to evaluate the sustainability and societal impact of a corporation or business.

The concept has become a buzzword in global business over the past several years.

이 기사를 공유합니다
Copyright © The Korea News Plus